Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Prospects for a genomic approach to the treatment of alcoholism.

O'Brien CP.

Arch Gen Psychiatry. 2008 Feb;65(2):132-3. doi: 10.1001/archgenpsychiatry.2007.32. No abstract available.

PMID:
18250250
[PubMed - indexed for MEDLINE]
2.

Questionable efficacy for naltrexone in patients with Asp40.

Mattes JA.

Arch Gen Psychiatry. 2009 Jul;66(7):796; author reply 796-7. doi: 10.1001/archgenpsychiatry.2009.68. No abstract available.

PMID:
19581571
[PubMed - indexed for MEDLINE]
3.

Pharmacogenetics of alcoholism: a clinical neuroscience perspective.

Ray LA, Courtney KE, Bujarski S, Squeglia LM.

Pharmacogenomics. 2012 Jan;13(2):129-32. doi: 10.2217/pgs.11.173. No abstract available.

PMID:
22256863
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Preserved DNA from past clinical trials yields new information about a subtype of alcoholism.

O'Brien CP.

Curr Psychiatry Rep. 2008 Oct;10(5):375-6. No abstract available.

PMID:
18803909
[PubMed - indexed for MEDLINE]
5.

Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.

Ray LA, Chin PF, Miotto K.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):13-22. Review.

PMID:
20201811
[PubMed - indexed for MEDLINE]
6.

The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers.

Mitchell JM, Fields HL, White RL, Meadoff TM, Joslyn G, Rowbotham MC.

J Clin Psychopharmacol. 2007 Feb;27(1):112-5. No abstract available.

PMID:
17224736
[PubMed - indexed for MEDLINE]
7.

The genetics of alcoholism.

Stacey D, Clarke TK, Schumann G.

Curr Psychiatry Rep. 2009 Oct;11(5):364-9. Review.

PMID:
19785977
[PubMed - indexed for MEDLINE]
8.

A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients.

Kim SG, Kim CM, Choi SW, Jae YM, Lee HG, Son BK, Kim JG, Choi YS, Kim HO, Kim SY, Oslin DW.

Psychopharmacology (Berl). 2009 Jan;201(4):611-8. doi: 10.1007/s00213-008-1330-5. Epub 2008 Sep 16.

PMID:
18795264
[PubMed - indexed for MEDLINE]
9.

Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.

Barr CS, Chen SA, Schwandt ML, Lindell SG, Sun H, Suomi SJ, Heilig M.

Biol Psychiatry. 2010 Jan 1;67(1):78-80. doi: 10.1016/j.biopsych.2009.07.026. Epub .

PMID:
19748082
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Study suggests gene may predict success of therapies for alcohol dependence.

Kuehn BM.

JAMA. 2011 Mar 9;305(10):984-5. doi: 10.1001/jama.2011.270. No abstract available.

PMID:
21386072
[PubMed - indexed for MEDLINE]
11.

The μ-opioid receptor and treatment response to naltrexone.

Thorsell A.

Alcohol Alcohol. 2013 Jul-Aug;48(4):402-8. doi: 10.1093/alcalc/agt030. Epub 2013 Mar 29. Review.

PMID:
23543091
[PubMed - indexed for MEDLINE]
Free Article
12.

COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.

Goldman D, Oroszi G, O'Malley S, Anton R.

J Stud Alcohol Suppl. 2005 Jul;(15):56-64; discussion 33. Review.

PMID:
16223057
[PubMed - indexed for MEDLINE]
13.

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.

Oslin DW, Berrettini WH, O'Brien CP.

Addict Biol. 2006 Sep;11(3-4):397-403. Review.

PMID:
16961767
[PubMed - indexed for MEDLINE]
14.

The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF.

Alcohol Clin Exp Res. 2012 Mar;36(3):385-94. doi: 10.1111/j.1530-0277.2011.01633.x. Epub 2011 Sep 6. Review.

PMID:
21895723
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pharmacogenetic treatments for drug addiction: alcohol and opiates.

Haile CN, Kosten TA, Kosten TR.

Am J Drug Alcohol Abuse. 2008;34(4):355-81. doi: 10.1080/00952990802122564. Review.

PMID:
18584566
[PubMed - indexed for MEDLINE]
16.

Toward a rational selection of treatment for addiction.

O'Brien CP.

Curr Psychiatry Rep. 2007 Dec;9(6):441-2. No abstract available.

PMID:
18221622
[PubMed - indexed for MEDLINE]
17.

Genes harbor clues to addiction, recovery.

Hampton T.

JAMA. 2004 Jul 21;292(3):321-2. No abstract available.

PMID:
15265836
[PubMed - indexed for MEDLINE]
18.

Naltrexone hydrochloride use in the treatment of alcoholism.

Ey SR.

West J Med. 1996 Oct;165(4):227. No abstract available.

PMID:
8987434
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Findings on alcohol dependence point to promising avenues for targeted therapies.

Kuehn BM.

JAMA. 2009 Apr 22;301(16):1643-5. doi: 10.1001/jama.2009.535. No abstract available.

PMID:
19383946
[PubMed - indexed for MEDLINE]
20.

Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data.

Lê AD, Tomkins DM, Sellers EM.

Alcohol Alcohol. 1996 Mar;31 Suppl 1:27-32. Review.

PMID:
8736998
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk